The European Union’s trade relationship with China has moved past cyclical friction into what looks increasingly like a structural realignment one where goods trade imbalances, sector-specific trade defence, and diverging investment flows are compounding simultaneously. For chemical market participants specifically, this realignment carries outsized relevance: chemicals sit at the centre of the EU’s trade-defence caseload, carry a disproportionate export dependency on the Chinese market, and are the subject of the bloc’s most consequential antidumping rulings in recent memory.

The Deficit: Volume Growing Faster than Value

The EU’s goods trade deficit with China reached €359.9 billion (~$411.4 billion) in 2025, up 2.7 per cent year-on-year (YoY) from €312.2 billion in 2024, though still below the 2022 peak of €397.3 billion. The more technically significant figure sits beneath the headline number: deficit volume climbed from 44.8 million tonnes in 2024 to 58.1 million tonnes in 2025, and across the 2015–2025 decade the deficit expanded 5.2-fold in tonnage against only a 2.4-fold increase in value.

The technical implication is straightforward: China’s export mix into the EU has shifted toward higher-tonnage, lower-value-per-unit product, the pattern trade economists associate with overcapacity being absorbed through export channels rather than domestic consumption. Bilateral trade flow reinforces the asymmetry: China became the EU’s fourth-largest export destination (behind Switzerland) while remaining its single largest import source. EU exports to China fell 6.5 per cent YoY to €199.5 billion in 2025, while imports from China rose 6.4 per cent to €559.5 billion.

Where Chemicals Sit in the Flow

Manufactured goods dominate both directions of trade, 97.3 per cent of EU imports from China and 86.2 per cent of EU exports to China in 2025, but the category-level split reveals the sector’s specific exposure.

Chemicals represent 16.2 per cent of what the EU exports to China versus only 9.8 per cent of what it imports, a structural mismatch that Cefic’s trade experts have repeatedly cited as a retaliation risk, since the European chemical industry generates over 30 per cent of its total sales abroad. In absolute terms, EU chemical imports from China reached roughly $66.6 billion in 2024, approximately double the level of a decade earlier, even as the sector’s share of total import volume remains comparatively modest next to machinery and vehicles.

Trade Defence: Duty Rates by Product

Brussels’ policy response has moved from strategy documents into enforceable duty schedules. The chemical sector accounts for between one-third and one-half of all active DG Trade investigations, according to Cefic estimates, and recent rulings show the scale of pricing distortion the Commission has identified in specific product markets.

The phosphorous acid ruling a 122.8 per cent definitive duty imposed in March 2026 on a market worth just €18 million domestically, with the entire €9.7 million import volume sourced from China illustrates how narrowly the Commission can target a single product line once dumping is established. Adipic acid, a direct precursor for polyamide and polyester polyol production, drew duties in the 30–40 per cent range in May 2026, a ruling with direct relevance to nylon and polyamide-linked value chains. For context, the chart also shows the more aggressive US posture on MDI (methylene diphenyl diisocyanate), where duties reach over 150 per cent for non-named Chinese producers, a benchmark EU trade-defence advocates have cited when arguing Brussels’ response remains comparatively measured.

Capacity Attrition on the EU Side

The counterpart to Chinese capacity expansion has been sustained EU capacity contraction. Cefic data show cumulative European chemical plant closures reaching 37 million tonnes, roughly 9 per cent of total EU production capacity since 2022, a sixfold increase in closure activity over that period, with an associated loss of 20,000 direct jobs.

This closure trend is the operational consequence of the capacity gap Wood Mackenzie has quantified at the global level: China now holds approximately 23 per cent of global ethylene capacity, having installed more new ethylene and propylene capacity between 2019 and 2024 than the combined existing base of Europe, Japan, and South Korea. Europe’s own ethylene share has fallen to roughly 10 per cent of global capacity. Analysts note some Chinese facilities operate at utilisation rates as low as 50 per cent, a level that would be commercially unviable under the roughly 80 per cent threshold typically required for economic viability in Western operating models, underscoring that continued Chinese output expansion is being sustained through policy tolerance rather than conventional unit economics.

Investment Flows: The Divergence Beneath the Trade Data

The most consequential shift for market participants may not be in goods trade at all, but in capital flow direction. EU investment stock in China stood at €239.3 billion in 2024, roughly three times China’s €79.8 billion investment stock in the EU; yet the flow trajectory has inverted.

*Note: exact 2024 and Q3 2025 point values for EU-into-China FDI, and the Q3 2025 point for China-into-EU FDI, are interpolated between the disclosed anchor figures (EU: €10.1bn in 2023 down to €1.1bn in Q3 2025, the lowest in eight quarters; China: €6.4bn in 2023 up to €10.6bn in 2024, with a reported Q3 2025 rebound in acquisition activity) to illustrate the trend direction, treat the endpoints as the reliable data points.

EU FDI flow into China fell to just €1.1 billion in Q3 2025, the weakest quarterly figure in eight quarters, even as EU investment continues to concentrate in automotive, pharmaceuticals and biotechnology, and basic materials, sectors where European firms retain clear technological differentiation. Chinese FDI into the EU has moved in the opposite direction, rising from €6.4 billion in 2023 to €10.6 billion in 2024, concentrated in automotive, entertainment/media/education, and energy and basic materials. Notably, Q3 2025 data show a rebound specifically in Chinese acquisition activity into the EU, alongside continued greenfield investment in automotive and technology, even as the count of new investment initiatives declined, a pattern consistent with more selective, larger-ticket Chinese capital deployment rather than broad-based retrenchment.

Synthesis: A Three-Layer Realignment

First, at the trade layer, volume growth is outpacing value growth, consistent with overcapacity-driven export pricing. Second, at the policy layer, chemical-specific antidumping enforcement has moved from strategy documents into duty rates exceeding 100 per cent on targeted products, with the sector absorbing a disproportionate share of the EU’s total trade-defence caseload. Third, at the capital layer, European firms are pulling back from fresh investment in China even as Chinese capital increasingly acquisition-led rather than greenfield continues flowing into European assets.

For chemical market participants, the practical implication is that trade-defense measures alone will not resolve the underlying imbalance. Duties on individual products like phosphorous acid and adipic acid address specific dumping findings, but the structural driver’s Chinese capacity scale, EU energy cost disadvantage, and a widening capital-flow asymmetry point toward a longer adjustment cycle. The EU’s own framing of this as “de-risking, not decoupling” suggests continued selective trade defence alongside sustained bilateral dialogue through the Annual EU-China Summit and the High-Level Economic and Trade Dialogue, rather than a decisive rupture in either direction.